In the present article, we demonstrated that CDK8/19i SenB and SNX631 sensitized K562 CML cells to various BCR-ABLi (Fig. 2A–D). This evidence concerns the gene CDK8 and chronic myelogenous leukemia, BCR-ABL1 positive.